Trials / Completed
CompletedNCT00918736
Efficacy of 3 Weekly Injections of Hyaluronate in Patients With Ankle Osteoarthritis
Hyaluronans in the Treatment of Ankle Osteoarthritis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Kaohsiung Veterans General Hospital. · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study was to investigate the efficacy and safety of three weekly intraarticular injections of Hyaluronate (HA) in patients with unilateral ankle Osteoarthritis (OA).
Detailed description
Viscosupplementation with 3 to 5 weekly hyaluronate injections is a well-established treatment option in knee osteoarthritis. Previous studies reported that five weekly hyaluronate injections were safe and effective for the treatment of ankle osteoarthritis. However, the effect of three weekly injections has rarely been investigated. Besides, no study to date has assessed whether balance function would change after HA injections in patients with ankle OA. The purpose of this study was to evaluate the efficacy and safety of three weekly injections of sodium hyaluronate (Hyalgan) in patients with unilateral ankle osteoarthritis. Pain, physical function and balance will be assessed as parameters for the effectiveness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sodium hyaluronate | 3 weekly intraarticular injections of 2 ml sodium hyaluronate (Hyalgan) into the ankle joints. |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2008-10-01
- Completion
- 2008-10-01
- First posted
- 2009-06-11
- Last updated
- 2009-06-17
- Results posted
- 2009-06-11
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00918736. Inclusion in this directory is not an endorsement.